Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 2022 11 Noviembre 2022 News Veterinary Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022 11 Noviembre 2022 News Human COVID-19 Medicines New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 11 Noviembre 2022 News Human Referrals EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines 11 Noviembre 2022 News Human Referrals EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine 11 Noviembre 2022 News Human COVID-19 Vaccines Regulatory update - EMA encourages companies to submit type I variations for 2022 by end of November 3 Noviembre 2022 News Corporate Medicines EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 3 Noviembre 2022 News Human Referrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022 28 Octubre 2022 News Human Pharmacovigilance Referrals EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines 28 Octubre 2022 News Human Medicines Referrals EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 28 Octubre 2022 News Corporate COVID-19 1 … 33 34 35 36 37 Page 37 of 380 38 39 40 41 … 380
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 2022 11 Noviembre 2022 News Veterinary Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022 11 Noviembre 2022 News Human COVID-19 Medicines
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 11 Noviembre 2022 News Human Referrals
EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines 11 Noviembre 2022 News Human Referrals
EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine 11 Noviembre 2022 News Human COVID-19 Vaccines
Regulatory update - EMA encourages companies to submit type I variations for 2022 by end of November 3 Noviembre 2022 News Corporate Medicines
EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 3 Noviembre 2022 News Human Referrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022 28 Octubre 2022 News Human Pharmacovigilance Referrals
EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines 28 Octubre 2022 News Human Medicines Referrals
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 28 Octubre 2022 News Corporate COVID-19